A budget proposal from the Legislature calls for the allocation of nearly $30 million from the fund, which includes money from Oklahoma’s settlements with Teva Pharmaceuticals USA and Endo Pharmaceuticals, the article reads. The money will be divided among several agencies and used for “opioid abatement,” although some lawmakers said there were questions if the language in the appropriation bill effectively guarantees the money would be used solely for that purpose.

Read the full story from The Oklahoman.